Aravive, Inc. (ARAV:NASDAQ) shot up at $0.19, a gain of 31.7%. On Fri, Oct 20, 2023, ARAV:NASDAQ touched a New 2-Week Intraday High of $0.25. From Fri, Oct 06, 2023, the stock recorded 30.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Oct 18, 2023 at $0.29 with a volume of 43M+.
About Aravive, Inc. (ARAV:NASDAQ)
Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 100.63%
- Golden Minerals Company (AUMN:NYSEMKT), 49.61%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 38.69%
- Nouveau Monde Graphite Inc. (NMG:NYSE), 36.63%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 36.11%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 35.32%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 34.84%
- Aravive, Inc. (ARAV:NASDAQ), 31.75%
- FLJ Group Limited (FLJ:NASDAQ), 31.05%
- Northann Corp. (NCL:NYSEMKT), 30.43%